124 related articles for article (PubMed ID: 1933783)
1. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases.
Prat J; Matias-Guiu X; Barreto J
Cancer; 1991 Dec; 68(11):2455-9. PubMed ID: 1933783
[TBL] [Abstract][Full Text] [Related]
2. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D
Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.
Halperin R; Zehavi S; Hadas E; Habler L; Bukovsky I; Schneider D
Int J Gynecol Cancer; 2003; 13(1):32-7. PubMed ID: 12631217
[TBL] [Abstract][Full Text] [Related]
5. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases.
Ulbright TM; Roth LM
Hum Pathol; 1985 Jan; 16(1):28-34. PubMed ID: 2982713
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.
Smit VT; Fleuren GJ; van Houwelingen JC; Zegveld ST; Kuipers-Dijkshoorn NJ; Cornelisse CJ
Cancer; 1990 Oct; 66(8):1843-9. PubMed ID: 2208040
[TBL] [Abstract][Full Text] [Related]
7. Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis.
Kaneki E; Oda Y; Ohishi Y; Tamiya S; Oda S; Hirakawa T; Nakano H; Tsuneyoshi M
Hum Pathol; 2004 Dec; 35(12):1484-93. PubMed ID: 15619207
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract][Full Text] [Related]
9. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
10. [Metastatic tumors in the ovary, difficulties of histologic diagnosis].
Tamás J; Vereczkey I; Tóth E
Magy Onkol; 2015 Sep; 59(3):205-13. PubMed ID: 26339910
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus.
Eifel P; Hendrickson M; Ross J; Ballon S; Martinez A; Kempson R
Cancer; 1982 Jul; 50(1):163-70. PubMed ID: 7083121
[TBL] [Abstract][Full Text] [Related]
12. Feulgen cytometry in simultaneous endometrial and ovarian carcinoma.
Symonds DA; Johnson DP; Wheeless CR
Cancer; 1988 Jun; 61(12):2511-6. PubMed ID: 3365672
[TBL] [Abstract][Full Text] [Related]
13. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
15. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers.
Guerra F; Girolimetti G; Perrone AM; Procaccini M; Kurelac I; Ceccarelli C; De Biase D; Caprara G; Zamagni C; De Iaco P; Santini D; Gasparre G
Mod Pathol; 2014 Oct; 27(10):1412-20. PubMed ID: 24633194
[TBL] [Abstract][Full Text] [Related]
17. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
[TBL] [Abstract][Full Text] [Related]
18. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
[TBL] [Abstract][Full Text] [Related]
19. Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors.
Nishimura N; Hachisuga T; Nabeshima K; Kawarabayashi T
Int J Oncol; 2005 Dec; 27(6):1519-26. PubMed ID: 16273207
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
